Patent Assignment
Reel/Frame 073619/0218
Assignment of Assignor's Interest
Recorded: 2026-01-28
Pages: 5
Assignor
POTTERFIELD, RUSSELL
Executed: 2026-01-27
Assignee
ENDEVICA BIO, INC.
1935 TECHNY ROAD, SUITE 14, NORTHBROOK, ILLINOIS, 60062
Covered Properties
(8)
Methods of Treating Cancer and/or Chemotherapy Related Conditions Using Non-Naturally Occuring Melanocortin Analogs
Application:
19/158,032 →
Methods of Stimulating Appetite and/or Increasing Body Weight Using Non-Naturally Occurring Melanocortin Receptor Antagonist Analogs
Application:
19/183,258 →
Methods of Preventing and/or Treating Side Effects Associated with Anti-Cancer Agents Using Non-Naturally Occurring Melanocortin Analogs with Anti-Gdf-15 Antibodies
Application:
19/157,332 →
Formulation for Oral Administration of Non-Naturally Occurring Melanocortin Receptor Antagonist Analogs
Application:
63/759,023 →
Formulation for Oral Administration of Non-Naturally Occurring Melanocortin Receptor Agonist Analogs
Application:
63/759,020 →
Formulations for Oral Administration of Non-Naturally Occurring Melanocortin Receptor Analogs
Application:
63/759,024 →
Methods of Treating Cancer and/or Chemotherapy Related Conditions Using Non-Naturally Occurring Melanocortin Analogs
PCT:
PCT/US2024/016295 ↗
Methods of Preventing and/or Treating Side Effects Associated with Anti-Cancer Agents Using Non-Naturally Occurring Melanocortin Analogs with Anti-Gdf-15 Antibodies
PCT:
PCT/US2024/016318 ↗
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.